Adamis Pharmaceuticals Announces Third Quarter 2023 Financial Results and Provides Corporate Update
SAN DIEGO, Nov. 22, 2023 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing specialty products for allergy, opioid overdose, respiratory and inflammatory disease, today announced financial results for the nine months ended September 30,…